| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,242 |
18,877 |
$795K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
3,249 |
3,221 |
$172K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
2,236 |
2,042 |
$59K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
701 |
688 |
$40K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,151 |
2,127 |
$27K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,181 |
2,886 |
$27K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
683 |
590 |
$22K |
| 90688 |
|
959 |
953 |
$13K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
587 |
498 |
$7K |
| 90756 |
|
425 |
425 |
$7K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
96 |
94 |
$5K |
| 99050 |
|
873 |
835 |
$5K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
448 |
425 |
$5K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
171 |
163 |
$4K |
| 90686 |
|
226 |
226 |
$3K |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
42 |
39 |
$2K |
| 99441 |
|
136 |
130 |
$2K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
65 |
65 |
$2K |
| 99385 |
|
27 |
27 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,211 |
1,206 |
$2K |
| 90674 |
|
40 |
40 |
$949.53 |
| 90715 |
|
26 |
26 |
$868.77 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
27 |
25 |
$821.34 |
| 90473 |
|
28 |
28 |
$388.75 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
14 |
14 |
$198.00 |
| 99051 |
|
593 |
511 |
$165.00 |
| 93000 |
|
14 |
14 |
$108.00 |
| 86580 |
|
15 |
15 |
$95.31 |
| G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion |
13 |
13 |
$78.50 |
| 90672 |
|
28 |
28 |
$70.64 |
| 90682 |
|
22 |
22 |
$49.08 |
| 3078F |
|
291 |
272 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
459 |
406 |
$0.00 |
| 3008F |
|
317 |
294 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
463 |
411 |
$0.00 |
| 3074F |
|
352 |
325 |
$0.00 |
| 3075F |
|
28 |
28 |
$0.00 |
| 3079F |
|
146 |
132 |
$0.00 |
| 3044F |
|
52 |
47 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
90 |
80 |
$0.00 |